News
Egle Therapeutics to Highlight Novel Preclinical Findings for Regulatory T Cells Targeting Programs EGL-001 and EGL-002 With Poster Presentations at the 2025 AACR Annual Meeting Egle Therapeutics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback